Novo Nordisk has won a contract as the primary supplier of insulin to American war veterans. The contract, signed with the U.S. Department of Veterans Affairs, runs one year from 1 March. The U.S. Department of Veterans Affairs has the option to renew the contract annually for up to four additional years. (Source: RB-Børsen)

This entry was posted on Thursday, March 4th, 2010 at 9:48 am by David Hoskin and is filed under Business, Global Denmark. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.